Alvotech (ALVO): Next-Year EPS Estimate 342.48%
As of 2026-06-11, Alvotech (ALVO) has a next-year EPS growth estimate of 342.48%.
On 2026-06-03, analyst consensus for ALVO's next-year EPS growth shifted from 246.11% to 342.48% — a positive change of 96.37 percentage points. The revised estimate has been sustained across 7 subsequent trading sessions. Current-year growth is projected at 145.59%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 342.48%
- EPS growth this year
- 145.59%
- EPS next quarter (est)
- -$0.02
- Last price
- $4.22
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 342.48% | 145.59% | -$0.02 | $4.22 |
| 2026-06-10 | 342.48% | 145.59% | -$0.02 | $4.14 |
| 2026-06-09 | 342.48% | 145.59% | -$0.02 | $4.16 |
| 2026-06-08 | 342.48% | 145.59% | -$0.02 | $4.24 |
| 2026-06-07 | 342.48% | 145.59% | -$0.02 | $3.54 |
| 2026-06-04 | 342.48% | 145.59% | -$0.02 | $3.74 |
| 2026-06-03 | 342.48% | 145.59% | -$0.02 | $3.14 |
| 2026-06-02 | 246.11% | 162.16% | -$0.02 | $3.00 |
| 2026-06-01 | 246.11% | 162.16% | -$0.02 | $3.22 |
| 2026-05-31 | 246.11% | 162.16% | -$0.02 | $3.36 |
| 2026-05-28 | 246.11% | 162.16% | -$0.02 | $3.43 |
| 2026-05-27 | 246.11% | 162.16% | -$0.02 | $3.44 |
| 2026-05-26 | 246.11% | 162.16% | -$0.02 | $3.42 |
| 2026-05-25 | 246.11% | 162.16% | -$0.02 | $3.34 |
| 2026-05-24 | 246.11% | 162.16% | -$0.02 | $3.34 |
| 2026-05-21 | 246.11% | 162.16% | -$0.02 | $3.38 |
| 2026-05-20 | 246.11% | 162.16% | -$0.02 | $3.30 |
| 2026-05-19 | 246.11% | 162.16% | -$0.02 | $3.28 |
| 2026-05-18 | 246.11% | 162.16% | -$0.02 | $3.25 |
| 2026-05-17 | 246.11% | 162.16% | -$0.02 | $3.31 |
| 2026-05-14 | 262.79% | 159.30% | -$0.02 | $3.43 |
| 2026-05-13 | 262.79% | 159.30% | -$0.02 | $3.65 |
| 2026-05-12 | 262.79% | 159.30% | -$0.02 | $3.55 |
| 2026-05-11 | 262.79% | 159.30% | -$0.02 | $3.59 |
| 2026-05-10 | 248.85% | 161.66% | -$0.02 | $3.26 |
| 2026-05-07 | 248.85% | 161.66% | -$0.02 | $3.20 |
| 2026-05-06 | 646.77% | 128.81% | -$0.05 | $3.57 |
| 2026-05-05 | 646.77% | 128.81% | -$0.05 | $3.50 |
| 2026-05-04 | 646.77% | 128.81% | -$0.05 | $3.52 |
| 2026-05-03 | 673.96% | 125.95% | -$0.05 | $3.46 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Alvotech's next-year EPS growth estimate?▾
As of 2026-06-11, Alvotech (ALVO) has a next-year EPS growth estimate of 342.48%, based on analyst consensus.
When was the latest EPS estimate revision for ALVO?▾
The most recent revision occurred on 2026-06-03, when analysts adjusted the next-year EPS growth estimate from 246.11% to 342.48%.
What sector and industry does Alvotech belong to?▾
Alvotech operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ALVO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Alvotech (ALVO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports